skin boosters
Scope
Date
~
-
Beauty & Cosmetics
In China’s waterway city Hangzhou, K-beauty redefines ‘shuiguang'
HANGZHOU – The capital of China’s Zhejiang province, Hangzhou, is the southern terminus of the ancient Grand Canal waterway, which origi...
May 12, 2025 (Gmt+09:00)
-
Mergers & Acquisitions
LG Chem embarks on sale of dermal filler business worth $343 million
LG Chem Ltd., the world’s fourth-largest chemicals producer that is fostering vaccine and new drug development as new growth drivers, has kick...
Feb 09, 2025 (Gmt+09:00)
-
Beauty & Cosmetics
Cosmax, Fudan Univ. to team up for microbiome research
Cosmax Inc., South Korea's largest cosmetics original development and design manufacturer (ODM), said on Friday it signed a memorandum of understand...
Oct 25, 2024 (Gmt+09:00)
-
Healthcare
Korea’s booming medical tourism: Skin care, plastic surgery in demand
The number of foreign patients visiting South Korea for medical tourism hit a record high last year, driven by those who traveled to Korea for skin ...
Apr 29, 2024 (Gmt+09:00)
-
Beauty & Cosmetics
Cosmax opens integrated R&D center for bio-material
Cosmax Group, South Korea's largest cosmetics manufacturer specializing in original design manufacturing (ODM), announced on Monday that it has la...
Feb 05, 2024 (Gmt+09:00)
-
Bio & Pharma
GI Innovation transfers allergy treatment tech to Japan
South Korea's GI Innovation Inc. announced on Monday it has transferred its allergy treatment "GI-301" to the Japanese pharmaceutical company Maruho...
Oct 16, 2023 (Gmt+09:00)
-
Beauty & Cosmetics
S.Korean gov't, L'Oréal to jointly support beauty tech startups
South Korean Ministry of SMEs and Startups has joined forces with the L'Oréal Group to provide support for beauty tech startups.During the Vi...
Jun 16, 2023 (Gmt+09:00)
-
Earnings
Poshmark powers Naver earnings; HyperCLOVA X the next booster
South Korea’s online giant Naver Corp. reported better-than-expected quarterly earnings thanks to strong sales of Poshmark Inc. in the US. It ...
May 09, 2023 (Gmt+09:00)
-
Bio & Pharma
Phase 3 clinical plan for SK Bioscience's booster shot approved in Colombia
SK Bioscience Co., a leading South Korean vaccine and biotech company, announced on Monday that its phase 3 clinical trial plan for a heterogeneous ...
Mar 07, 2023 (Gmt+09:00)
-
Bio & Pharma
Korean biotech L&C Bio issues convertible bonds worth $46 mn
South Korean biotech company L&C Bio, which specializes in tissue regeneration treatment, is poised to ramp up its expansion into the Chinese ma...
Jun 30, 2022 (Gmt+09:00)
language
Latest News
- 1 SK Group seeks to sell SK Signet as part of sweeping portfolio realignment
- 2 Korean firms rush to issue bonds before presidential election
- 3 Hong Kong to list world’s first Samsung single-stock leverage ETF
- 4 Samsung bets on data center HVAC with $1.7 bn FläktGroup acquisition
- 5 Hanjin KAL roars on renewed control dispute hints with Hoban